|
|
Volumn 4, Issue 5, 2002, Pages 427-434
|
|
New developments in the diagnosis and treatment of irritable bowel syndrome.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
ANTIINFECTIVE AGENT;
CARBOLINE DERIVATIVE;
GASTROINTESTINAL AGENT;
INDOLE DERIVATIVE;
TEGASEROD;
CELIAC DISEASE;
CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
FEMALE;
FORECASTING;
HOSPITALIZATION;
HUMAN;
IRRITABLE COLON;
MALE;
PROGNOSIS;
REVIEW;
RISK ASSESSMENT;
ANTI-BACTERIAL AGENTS;
CARBOLINES;
CELIAC DISEASE;
CLINICAL TRIALS;
COLONIC DISEASES, FUNCTIONAL;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
FORECASTING;
GASTROINTESTINAL AGENTS;
HUMANS;
INDOLES;
MALE;
PROGNOSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 0036782165
PISSN: 15228037
EISSN: None
Source Type: Journal
DOI: 10.1007/s11894-002-0014-2 Document Type: Review |
|
Times cited : (17)
|
|
References (39)
|
